Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Levetiracetam for seizure prophylaxis in brain tumor surgery
2015-003916-19Phase 2Terminated
- Sponsor
- Karl Landsteiner Institute for Clinical Neurology and Neuropsychology
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levetiracetam in brain neoplasm and epilepsy, sponsored by Karl Landsteiner Institute for Clinical Neurology and Neuropsychology. Primary endpoint: Occurrence of epileptic seizures. Started Nov 2015; status: terminated.
02
Drugs
levetiracetam
03
Conditions
brain neoplasmepilepsy
Beyond the preview
Go deeper on 2015-003916-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003916-19.